These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 24966603)

  • 1. Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue.
    Kwanten WJ; Martinet W; Michielsen PP; Francque SM
    World J Gastroenterol; 2014 Jun; 20(23):7325-38. PubMed ID: 24966603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy and Lipid Droplets in the Liver.
    Martinez-Lopez N; Singh R
    Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.
    Grefhorst A; van de Peppel IP; Larsen LE; Jonker JW; Holleboom AG
    Front Endocrinol (Lausanne); 2020; 11():601627. PubMed ID: 33597924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways of nonalcoholic fatty liver disease development and progression.
    Bessone F; Razori MV; Roma MG
    Cell Mol Life Sci; 2019 Jan; 76(1):99-128. PubMed ID: 30343320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy, NAFLD and NAFLD-Related HCC.
    Wu WKK; Zhang L; Chan MTV
    Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging.
    Gong Z; Tas E; Yakar S; Muzumdar R
    Mol Cell Endocrinol; 2017 Nov; 455():115-130. PubMed ID: 28017785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy in nonalcoholic steatohepatitis.
    Amir M; Czaja MJ
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):159-66. PubMed ID: 21476911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease.
    Tang M; Jiang Y; Jia H; Patpur BK; Yang B; Li J; Yang C
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):159-168. PubMed ID: 31852298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
    Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy in the liver: cell's cannibalism and beyond.
    Flores-Toro JA; Go KL; Leeuwenburgh C; Kim JS
    Arch Pharm Res; 2016 Aug; 39(8):1050-61. PubMed ID: 27515049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and liver disease.
    Quiñones M; Fernø J; Al-Massadi O
    Rev Endocr Metab Disord; 2020 Mar; 21(1):45-56. PubMed ID: 31758299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
    Zhao T; Wu K; Hogstrand C; Xu YH; Chen GH; Wei CC; Luo Z
    Cell Mol Life Sci; 2020 May; 77(10):1987-2003. PubMed ID: 31392349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Steatohepatitis.
    Suzuki A; Diehl AM
    Annu Rev Med; 2017 Jan; 68():85-98. PubMed ID: 27732787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.